Do catecholamines, such as epinephrine (adrenaline), have bronchodilatory effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Catecholamines and Their Bronchodilatory Effects

Catecholamines are naturally occurring and synthetic compounds that act on adrenergic receptors and cause bronchodilation through their action on beta-2 adrenergic receptors in the lungs, with epinephrine (adrenaline) being the most clinically significant example.

What Are Catecholamines?

Catecholamines are a class of chemical compounds that include both naturally occurring hormones and synthetic medications that:

  • Function as neurotransmitters and hormones in the body
  • Include epinephrine (adrenaline), norepinephrine (noradrenaline), and dopamine
  • Share a common chemical structure with a catechol nucleus and an amine group

Mechanism of Bronchodilation

Catecholamines cause bronchodilation primarily through their effects on adrenergic receptors:

  • Beta-2 adrenergic receptor stimulation: This is the primary mechanism for bronchodilation

    • Causes relaxation of bronchial smooth muscle 1
    • Alleviates bronchospasm and wheezing 1
    • Reduces airway resistance and improves airflow
  • Alpha-adrenergic effects: Some catecholamines (like epinephrine) also have alpha effects that:

    • May reduce airway edema 2
    • Decrease vascular permeability 1

Clinical Applications

Epinephrine (adrenaline) is the most clinically relevant catecholamine used for bronchodilation:

  1. Anaphylaxis: First-line treatment for bronchospasm associated with anaphylaxis 2, 1

    • Recommended dose: 0.3 mg IM for adults, 0.15 mg for children 15-30 kg 2
    • Alleviates bronchospasm, wheezing, and dyspnea 1
  2. Acute asthma exacerbations:

    • Historically used as a mainstay treatment 2
    • Can be administered subcutaneously (0.01 mg/kg, typically as 0.3 mg doses) 2
    • Modern guidelines generally favor selective beta-2 agonists over epinephrine 2
  3. Severe or life-threatening asthma:

    • Still used in some prehospital protocols 2
    • May be considered when selective beta-2 agonists are ineffective 2

Efficacy Compared to Selective Beta-2 Agonists

The evidence comparing epinephrine to selective beta-2 agonists shows:

  • Similar overall efficacy in acute asthma (pooled OR for treatment failure: 0.99) 2
  • Potentially better outcomes in adults compared to children 2
  • No proven advantage over inhaled beta-2 agonists in most situations 2

Potential Adverse Effects

Catecholamines can cause significant side effects due to their non-selective adrenergic activity:

  • Cardiovascular effects:

    • Increased heart rate and myocardial irritability 2
    • Potential for arrhythmias, especially with cardiac glycosides 1
    • Increased oxygen demand 2
    • Risk of precipitating cardiogenic shock in patients with left ventricular dysfunction 3
  • Metabolic effects:

    • Hyperglycemia 1
    • Increased blood lactic acid 1
  • Other effects:

    • Tremor and anxiety
    • Hypokalemia 2
    • Mydriasis (pupil dilation) 1

Clinical Considerations and Cautions

  1. Patient selection is crucial:

    • Avoid in patients with known cardiac disease when possible 3
    • Use with caution in patients >35 years of age 2
    • Consider cardiac status before administration 3
  2. Drug interactions:

    • Potentiated by tricyclic antidepressants and MAOIs 1
    • Antagonized by beta-blockers 1
    • Use cautiously with cardiac glycosides and antiarrhythmics 1
  3. Dosing considerations:

    • Allow sufficient time between doses for maximal effect 4
    • Repeated doses before peak effect may increase risk of adverse events 4

Summary

Catecholamines, particularly epinephrine, are effective bronchodilators that work primarily through beta-2 adrenergic receptor stimulation. While they have been largely replaced by selective beta-2 agonists for routine management of bronchospasm, epinephrine remains essential in anaphylaxis treatment and may still have a role in severe, life-threatening asthma exacerbations. The non-selective adrenergic effects of catecholamines contribute to their significant side effect profile, particularly cardiovascular effects, which must be carefully considered when using these agents.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.